Live Breaking News & Updates on Viral Hepatitis To Expand The Company Portfolio

Stay updated with breaking news from Viral hepatitis to expand the company portfolio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Assembly Biosciences to Introduce New Small Molecule Liver-Focused Interferon-α Receptor Agonist Research Program in Webcast on July 26, 2022

Assembly Bio leadership team will be joined by Professor Edward J. Gane, MBCHB, MD, FRACP, MNZM, an internationally-recognized hepatologist, and authority and investigator in hepatitis clinical. | June 21, 2022 ....

New Zealand , John Mchutchison , Shannon Ryan , William Delaney , Edwardj Gane , Viral Hepatitis To Expand The Company Portfolio , Assembly Bio Expertise In Small Molecules , Alliance Management , Receptor Agonist Research Program , Assembly Biosciences , Assembly Biosciences Inc , Sam Brown Inc , Exchange Commission , Securities Exchange , Risk Factors In Assembly Bio , Corporate Affairs , Assembly Bio Small Molecule Liver , Assembly Bio , Globenewswire Inc , Deputy Director , New Zealand Liver Unit , Chief Executive Officer , Small Molecules , Viral Hepatitis , Chief Scientific Officer , Securities Act ,